CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 162 filers reported holding CLOVIS ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $10,829,000 | +0.5% | 2,256,000 | +22.1% | 0.37% | -5.9% |
Q3 2020 | $10,774,000 | -0.2% | 1,848,000 | +15.5% | 0.39% | -17.5% |
Q2 2020 | $10,800,000 | +37.4% | 1,600,000 | +7900.0% | 0.47% | -9.0% |
Q3 2019 | $7,860,000 | -76.1% | 20,000 | -99.1% | 0.52% | -74.9% |
Q2 2019 | $32,946,000 | -36.8% | 2,215,600 | +5.5% | 2.08% | -27.2% |
Q1 2019 | $52,122,000 | -42.4% | 2,100,000 | -58.3% | 2.85% | -58.4% |
Q4 2018 | $90,447,000 | +88.2% | 5,036,000 | +207.8% | 6.86% | +137.7% |
Q3 2018 | $48,049,000 | +69.3% | 1,636,000 | +162.2% | 2.88% | +55.6% |
Q2 2018 | $28,373,000 | +14.8% | 624,000 | +33.3% | 1.85% | -2.0% |
Q1 2018 | $24,710,000 | – | 468,000 | – | 1.89% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |